Released Aug 9, 2013, after the close
10-Q filed Aug 9, 2013, 40 days after period end · 0001144204-13-044388
Q2 2013 · 10-Q
Revenue—
Net Income-$4.75M-$4.75M N/M vs Q2 2012N/M vs Q1 2013
EPS Diluted-$1.20-$1.20 N/M vs Q2 2012N/M vs Q1 2013
Operating Income-$4,808,759N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | -$4.75M | -$7.47M | -$6.96M | -$2.13M |
| EPS Diluted | -$1.20 | -$0.59 | -$0.97 | -$4.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR